voraxaze
(glucarpidase)BTG International Inc.
Usage: VORAXAZE is indicated for reducing toxic plasma methotrexate levels in adults and pediatric patients with delayed clearance due to impaired renal function. It should not be used in patients with expected clearance, as it may lead to inadequate methotrexate exposure.